[{"address1": "2 Bloor Street West", "address2": "Suite 903 7th Floor", "city": "Toronto", "state": "ON", "zip": "M4W 3E2", "country": "Canada", "phone": "416 648 5555", "website": "https://www.medicenna.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Medicenna Therapeutics Corp., a clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. It develops bizaxofusp, an interleukin- 4 (IL-4) targeted therapy for the treatment of recurrent glioblastoma. The company also develops MDNA11, a long-acting interleukin-2 (IL-2) to activate anti-cancer immune cells over immunosuppressive Tregs; MDNA209, an IL-2/IL-15 antagonist for autoimmune diseases, such as multiple sclerosis and graft versus host diseases; MDNA413, a dual IL-4/IL-13 antagonist to treat cancer immunotherapies; MDNA113, a tumor-targeting and activatable masked anti-PD-1-IL-2 BiSKITTM for cancer; and MDNA132, an IL-13 Superkine for various tumors. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Fahar  Merchant Ph.D.", "age": 68, "title": "Founder, Chairman, President & CEO", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 550572, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rosemina  Merchant B.Sc., M.E.Sc", "age": 68, "title": "Founder & Chief Development Officer", "yearBorn": 1957, "fiscalYear": 2025, "totalPay": 356133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Hyman CA, CBV", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1973, "fiscalYear": 2025, "totalPay": 86545, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel R. Denmeade M.D.", "title": "Scientific Advisor", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 7, "overallRisk": 9, "governanceEpochDate": 1767225600, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.678, "open": 0.6604, "dayLow": 0.6604, "dayHigh": 0.66705, "regularMarketPreviousClose": 0.678, "regularMarketOpen": 0.6604, "regularMarketDayLow": 0.6604, "regularMarketDayHigh": 0.66705, "payoutRatio": 0.0, "beta": 1.87, "forwardPE": -3.9235294, "volume": 20236, "regularMarketVolume": 20236, "averageVolume": 127220, "averageVolume10days": 96220, "averageDailyVolume10Day": 96220, "bid": 0.665, "ask": 0.6809, "bidSize": 6000, "askSize": 13000, "marketCap": 55635424, "fiftyTwoWeekLow": 0.573, "fiftyTwoWeekHigh": 1.43, "allTimeHigh": 6.84, "allTimeLow": 0.151, "fiftyDayAverage": 0.92738, "twoHundredDayAverage": 0.767455, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 40036428, "profitMargins": 0.0, "floatShares": 60632606, "sharesOutstanding": 83411435, "sharesShort": 109389, "sharesShortPriorMonth": 278169, "sharesShortPreviousMonthDate": 1694736000, "dateShortInterest": 1697155200, "sharesPercentSharesOut": 0.0016, "heldPercentInsiders": 0.20996, "heldPercentInstitutions": 0.06317, "shortRatio": 0.77, "shortPercentOfFloat": 0.0069999998, "impliedSharesOutstanding": 83411435, "bookValue": 0.08870883, "priceToBook": 7.5189805, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -13815000, "trailingEps": -0.12, "forwardEps": -0.17, "enterpriseToEbitda": -1.837, "52WeekChange": -0.28279573, "SandP52WeekChange": 0.19362879, "quoteType": "EQUITY", "currentPrice": 0.667, "targetHighPrice": 4.0, "targetLowPrice": 2.5, "targetMeanPrice": 3.25, "targetMedianPrice": 3.25, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 15748000, "totalCashPerShare": 0.189, "ebitda": -21798000, "totalDebt": 149000, "quickRatio": 3.815, "currentRatio": 4.008, "debtToEquity": 1.455, "returnOnAssets": -0.53507, "returnOnEquity": -0.91206, "freeCashflow": -9880250, "operatingCashflow": -17034000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "MDNAF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "regularMarketChangePercent": -1.6224157, "regularMarketPrice": 0.667, "marketState": "CLOSED", "corporateActions": [], "regularMarketTime": 1767992400, "exchange": "OQX", "messageBoardId": "finmb_245978917", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1510583400000, "regularMarketChange": -0.010999978, "regularMarketDayRange": "0.6604 - 0.66705", "fullExchangeName": "OTC Markets OTCQX", "averageDailyVolume3Month": 127220, "fiftyTwoWeekLowChange": 0.09399998, "fiftyTwoWeekLowChangePercent": 0.16404884, "fiftyTwoWeekRange": "0.573 - 1.43", "fiftyTwoWeekHighChange": -0.76299995, "fiftyTwoWeekHighChangePercent": -0.5335664, "fiftyTwoWeekChangePercent": -28.279573, "earningsTimestampStart": 1770930000, "earningsTimestampEnd": 1770930000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.12, "epsForward": -0.17, "fiftyDayAverageChange": -0.26038003, "fiftyDayAverageChangePercent": -0.2807695, "twoHundredDayAverageChange": -0.100454986, "twoHundredDayAverageChangePercent": -0.13089365, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "shortName": "Medicenna Therapeutics Corp.", "trailingPegRatio": null, "__fetch_time": "2026-01-10"}]